文献速递乳腺乳腺X线

乳腺导管起源癌伴碎裂铸型钙化与较差乳腺癌特异性生存相关

Neoduct dedifferentiation is associated with poorer breast cancer-specific survival.
PubMed 文献 · Eur J Radiol · 2026-08-27

结果显示伴碎裂铸型钙化的导管起源癌乳腺癌特异性生存显著差于分级匹配的腺泡起源癌(HR=2.54,95%CI 1.09-6.04)。2008-2022年期间腺泡起源癌生存改善(HR=1.90,95%CI 1.56-2.32),而导管起源癌长期生存未改善(HR=0.88,95%CI 0.56-1.38)。

要点

  • 乳腺X线上碎裂铸型钙化提示肿瘤起源于主导管,预后较差,报告中应明确描述并提示临床关注。
  • 导管起源癌在2008-2022年生存无改善,需重新评估当前诊疗策略。
  • 新导管边界破坏后细胞外溢形成星芒状/圆形肿块,可与新导管结构在原发及转移灶中共存。

核心结论

  • 伴碎裂铸型钙化的导管起源乳腺癌是一种侵袭性较强的亚型,其乳腺癌特异性生存显著差于分级匹配的腺泡起源癌。
  • 新生导管形成及细胞外溢形成肿块共同构成该亚型侵袭性生物学行为的基础,与较差生存相关。
  • 导管起源癌在近年未获得生存改善,提示当前诊断和治疗策略需重新评估。

研究设计与样本

  • 第一时段2359例、第二时段3553例乳腺癌患者中,前瞻性记录碎裂铸型钙化(导管起源)分别为161例和309例,星芒状/圆形肿瘤(腺泡起源)分别为1413例和2444例。
  • 采用寿命表法估计乳腺癌特异性生存,并按1:1分级匹配队列行Cox回归计算风险比,调整肿瘤大小、淋巴结状态和治疗。
  • 通过所有可用的临床、组织病理和影像资料对所有乳腺癌死亡病例进行死因精细评估。
  • 影像检查方式为乳腺X线摄影,以碎裂铸型钙化作为导管起源的生物标志物,星芒状/圆形肿块作为腺泡起源的标志。

关键影像表现/征象

  • 乳腺X线上碎裂铸型钙化提示恶性肿瘤起源于主导管,以新生导管形式增殖并可形成分散肿瘤灶。
  • 新生导管边界破坏后细胞内容物释放至间质间隙,形成乳腺X线上可检测的星芒状及圆形肿瘤肿块。
  • 新生导管样结构与导管外细胞成分并存于原发肿瘤以及淋巴结和远处转移灶中。

诊断标准与关键数值

  • 导管起源癌与腺泡起源癌分级匹配后,乳腺癌特异性生存风险比HR=2.54,95%CI 1.09-6.04。
  • 两个连续时间段比较显示腺泡起源癌生存显著改善,HR=1.90,95%CI 1.56-2.32。
  • 导管起源癌第二时段(2008-2022)长期生存未改善,HR=0.88,95%CI 0.56-1.38。
  • 乳腺X线碎裂铸型钙化作为导管起源的影像生物标志物,星芒状/圆形肿瘤作为腺泡起源的标志。

临床应用与阅片要点

  • 阅片时应注意区分碎裂铸型钙化的导管起源特征与星芒状/圆形肿块的腺泡起源特征,前者预后较差。
  • 报告中应明确描述碎裂铸型钙化的存在,提示临床关注该亚型的侵袭性行为和较差预后。
  • 注意导管起源癌可同时存在新生导管结构与导管外肿块成分,不要仅凭肿块形态忽略导管起源背景。

局限性

  • 单一地理医疗区的研究数据,结果的普遍性和外推性存在局限。
  • 研究为回顾性设计,虽然影像生物标志物为前瞻性记录,但可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Imaging biomarkers combined with large format histopathology have been shown to indicate the apparent site of breast cancer origin in either the major lactiferous ducts or the acini of the terminal ductal lobular units. The imaging biomarker of fragmented casting type calcifications on the mammogram provides a reliable indicator of a complex malignant tumour arising within the major lactiferous ducts, proliferating as neoducts, and eventually forming discrete tumour foci. The high fatality rate of this breast cancer subtype prompted our study.

METHOD: From our database of all breast cancer patients in two consecutive epochs, Jan 1st 1996-Dec 31st 2007 and Jan 1st 2008-June 30th 2022, in a single geographical healthcare district, we selected all women having prospectively documented fragmented casting type calcifications on the mammogram (ductal origin) (n = 161, n = 309 respectively) and stellate/circular tumours (apparent acinar origin) (n = 1,413, n = 2,444 respectively) from all women diagnosed with breast cancer in the first (n = 2359) and second (n = 3553) epochs. Breast cancer-specific survival was estimated by the life-table method, and the prognostic effect of the imaging biomarker was quantified as hazard ratios (95% CIs) from Cox regression in a 1:1 grade-matched cohort, adjusted for tumour size, nodal status and treatment. A refined assessment of cause of death was performed in all cases of breast cancer death from all available clinical, histopathologic and imaging data.

RESULTS: Women with the cancer subtype having casting type calcifications originating from the major lactiferous ducts had significantly poorer survival than women with grade matched cancers of apparent acinar origin (HR = 2.54, 95% CI 1.09-6.04). Comparison of the two consecutive epochs revealed a significant survival improvement in women with cancers of apparent acinar origin (HR = 1.90, 95% CI 1.56-2.32), whereas the long-term survival of cancers of ductal origin (HR = 0.88, 95% CI 0.56-1.38) did not improve during the second epoch (2008-2022). Breaches in the neoduct boundaries appear to release the cellular contents to the interstitial spaces, where they form mammographically detectable stellate and circular tumour masses, which co-exist with the neoducts in the primary tumours and in metastases to the lymph nodes and distant sites.

CONCLUSIONS: Our observations suggest that neoduct formation producing fragmented casting type calcifications on the mammogram is an invasive process, further exacerbated by the escape of the cellular contents from the neoducts to the surrounding extraductal space. We also propose that due to structural dedifferentiation the extraductal cells are no longer able to form neoducts but instead form tumour masses. The co-occurrence of neoduct-like structures and the extraductal cellular component, which is seen in both the primary and metastatic tumours, suggests a dependent relationship, the combination being responsible for the poor survival. The continuing poor outcome of these patients compared with the more recently improved outcome of patients with tumours of apparent acinar origin suggests a need to re-evaluate our current diagnostic and therapeutic strategies.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Tabár, Dean, Tucker, et al. Neoduct dedifferentiation is associated with poorer breast cancer-specific survival. Eur J Radiol. 2026. PMID: 42691750. doi:10.1016/j.ejrad.2026.113195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。